The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Myocardial Iodine-123 Meta-Iodobenzylguanidine Imaging and Cardiac Events in Heart Failure
Open accessAbstract
OBJECTIVES The ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study prospectively evaluated iodine-123 meta-iodobenzylguanidine ((123)I-mIBG) imaging for identifying symptomatic heart failure (HF) patients most likely to experience cardiac events. BACKGROUND Single-center studies have demonstrated the poorer prognosis of HF patients with reduced (123)I-mIBG myocardial uptake, but these observations have not been validated in large multicenter trials. METHODS A total of 961 subjects with New York Heart Association (NYHA) functional class II/III HF and left ventricular ejection fraction (LVEF) < or =35% were studied. Subjects underwent (123)I-mIBG myocardial imaging (sympathetic neuronal integrity quantified as the heart/mediastinum uptake ratio [H/M] on 4-h delayed planar images) and myocardial perfusion imaging and were then followed up for up to 2 years. Time to first occurrence of NYHA functional class progression, potentially life-threatening arrhythmic event, or cardiac death was compared with H/M (either in relation to estimated lower limit of normal [1.60] or as a continuous variable) using Cox proportional hazards regression. Multivariable analyses using clinical, laboratory, and imaging data were also performed. RESULTS A total of 237 subjects (25%) experienced events (median follow-up 17 months). The hazard ratio for H/M > or =1.60 was 0.40 (p < 0.001); the hazard ratio for continuous H/M was 0.22 (p < 0.001). Two-year event rate was 15% for H/M > or =1.60 and 37% for H/M <1.60; hazard ratios for individual event categories were as follows: HF progression, 0.49 (p = 0.002); arrhythmic events, 0.37 (p = 0.02); and cardiac death, 0.14 (p = 0.006). Significant contributors to the multivariable model were H/M, LVEF, B-type natriuretic peptide, and NYHA functional class. (123)I-mIBG imaging also provided additional discrimination in analyses of interactions between B-type natriuretic peptide, LVEF, and H/M. CONCLUSIONS ADMIRE-HF provides prospective validation of the independent prognostic value of (123)I-mIBG scintigraphy in assessment of patients with HF. (Meta-Iodobenzylguanidine Scintigraphy Imaging in Patients With Heart Failure and Control Subjects Without Cardiovascular Disease, NCT00126425; Meta-Iodobenzylguanidine [123I-mIBG] Scintigraphy Imaging in Patients With Heart Failure and Control Subjects Without Cardiovascular Disease, NCT00126438).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1990) · Choice Reviews Online · doi:10.5860/choice.27-3338 · Cited by 35,305
Hosmer, D. W., & Lemeshow, S. (2000) · doi:10.1002/0471722146 · Cited by 20,302
American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging:, Cerqueira, M. D., Weissman, N. J., Dilsizian, V., Jacobs, A. K., Kaul, S., Laskey, W. K., Pennell, D. J., Rumberger, J. A., Ryan, T., et al. (2002) · Circulation · doi:10.1161/hc0402.102975 · Cited by 6,990
Self-citation2005 WRITING COMMITTEE MEMBERS, Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192065 · Cited by 3,720
Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure
Cohn, J. N., Levine, T. B., Olivari, M. T., Garberg, V., Lura, D., Francis, G. S., Simon, A. B., & Rector, T. (1984) · New England Journal of Medicine · doi:10.1056/nejm198409273111303 · Cited by 3,125
Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts
Bristow, M. R., Ginsburg, R., Minobe, W., Cubicciotti, R. S., Sageman, W. S., Lurie, K., Billingham, M. E., Harrison, D. C., & Stinson, E. B. (1982) · New England Journal of Medicine · doi:10.1056/nejm198207223070401 · Cited by 2,270
Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.013 · Cited by 1,374
Leimbach, W. N., Wallin, B. G., Victor, R. G., Aylward, P. E., Sundlöf, G., & Mark, A. L. (1986) · Circulation · doi:10.1161/01.cir.73.5.913 · Cited by 812
Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure.
Merlet, P., Valette, H., Dubois-Randé, J. L., Moyse, D., Duboc, D., Dove, P., Bourguignon, M., Benvenuti, C., Duval, A., & Agostini, D. (1992) · PubMed · Cited by 580
Self-citationMeta-analysis: β-Blocker Dose, Heart Rate Reduction, and Death in Patients With Heart Failure
McAlister, F. A., Wiebe, N., Ezekowitz, J. A., Leung, A. A., & Armstrong, P. W. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-11-200906020-00006 · Cited by 479
Verberne, H. J., Brewster, L. M., Somsen, G. A., & van Eck-Smit, B. L. F. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn113 · Cited by 274
Role of the sympathetic nervous system in the genesis of ventricular arrhythmia.
Podrid, P. J., Fuchs, T., & Candinas, R. (1990) · PubMed · Cited by 262
Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy.
Merlet, P., Benvenuti, C., Moyse, D., Pouillart, F., Dubois‐Randé, J., Duval, A., Loisance, D. Y., Castaigne, A., & Syrota, A. (1999) · PubMed · Cited by 253
Tamaki, S., Yamada, T., Okuyama, Y., Morita, T., Sanada, S., Tsukamoto, Y., Masuda, M., Okuda, K., Iwasaki, Y., Yasui, T., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.10.025 · Cited by 235
Evidence for reduction of norepinephrine uptake sites in the failing human heart
Böhm, M., La Rosée, K., Schwinger, R. H. G., & Erdmann, E. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)00353-r · Cited by 235
Effect of cardiac sympathetic nervous activity on mode of death in congestive heart failure
Brunner-La Rocca, H. (2001) · European Heart Journal · doi:10.1053/euhj.2000.2407 · Cited by 224
Nakata, T., Miyamoto, K., Doi, A., Sasao, H., Wakabayashi, T., Kobayashi, H., Tsuchihashi, K., & Shimamoto, K. (1998) · Journal of Nuclear Cardiology · doi:10.1016/s1071-3581(98)90112-x · Cited by 188
Wakabayashi, T., Nakata, T., Hashimoto, A., Yuda, S., Tsuchihashi, K., Travin, M. I., & Shimamoto, K. (2001) · PubMed · Cited by 168
Nagahara, D., Nakata, T., Hashimoto, A., Wakabayashi, T., Kyuma, M., Noda, R., Shimoshige, S., Uno, K., Tsuchihashi, K., & Shimamoto, K. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.042564 · Cited by 139
Solal, A. C., Esanu, Y., Logeart, D., Pessione, F., Dubois, C., Dreyfus, G., Gourgon, R., & Merlet, P. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00608-1 · Cited by 130
Simoes, M. (2004) · European Heart Journal · doi:10.1016/j.ehj.2004.02.016 · Cited by 125
Backs, J., Haunstetter, A., Gerber, S. H., Metz, J., Borst, M. M., Strasser, R. H., Kübler, W., & Haass, M. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1319 · Cited by 116
Ungerer, M., Hartmann, F. S., Karoglan, M., Chlistalla, A., Ziegler, S., Richardt, G., Overbeck, M., Meisner, H., Schömig, A., & Schwaiger, M. (1998) · Circulation · doi:10.1161/01.cir.97.2.174 · Cited by 114
Jacobson, A. F., Lombard, J., Banerjee, G., & Camici, P. G. (2009) · Journal of Nuclear Cardiology · doi:10.1007/s12350-008-9008-2 · Cited by 112
Self-citationEffect of Beta-Blocker Therapy on Functional Status in Patients with Heart Failure — A Meta-Analysis
Abdulla, J., Køber, L., Christensen, E., & Torp-Pedersen, C. T. (2005) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2005.10.012 · Cited by 53
Cited by
Bairey Merz, C. N., Pepine, C. J., Walsh, M. N., Fleg, J. L., Camici, P. G., Chilian, W. M., Clayton, J. A., Cooper, L. S., Crea, F., Di Carli, M., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.024534 · Cited by 748
ASNC imaging guidelines for SPECT nuclear cardiology procedures: Stress, protocols, and tracers
Henzlova, M. J., Duvall, W. L., Einstein, A. J., Travin, M. I., & Verberne, H. J. (2016) · Journal of Nuclear Cardiology · doi:10.1007/s12350-015-0387-x · Cited by 700
Frantz, S., Hundertmark, M. J., Schulz-Menger, J., Bengel, F. M., & Bauersachs, J. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac223 · Cited by 606
The Autonomic Nervous System and Heart Failure
Florea, V. G., & Cohn, J. N. (2014) · Circulation Research · doi:10.1161/circresaha.114.302589 · Cited by 572
Fallavollita, J. A., Heavey, B. M., Luisi, A. J., Michalek, S. M., Baldwa, S., Mashtare, T. L., Hutson, A. D., deKemp, R. A., Haka, M. S., Sajjad, M., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.07.096 · Cited by 399
Metadata
- Authors
- Jacobson, A. F., Senior, R., Cerqueira, M. D., Wong, N. D., Thomas, G. S., Lopez, V. A., Agostini, D., Weiland, F., Chandna, H., & Narula, J.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2010-05
- Volume
- 55
- Issue
- 20
- Pages
- 2212-2221
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W1930119086
- Cited by
- 871
- References
- 25
- FWCI
- 43.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.